Ventas, Inc. Profile Avatar - Palmy Investing

Ventas, Inc.

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real est…
REIT - Healthcare Facilities
US, Chicago [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 33% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 15.72 0.85 0.73
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 6.34 29.20 27.46
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.99 23.31 23.54
Cash 22.06 1.71 1.40
Capex -35.29 -0.33 -0.25
Free Cash Flow -26.57 0.33 0.45
Revenue 2.96 2.97 2.89
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -69.57 0.18 -0.58
Operating Margin -79.12 0.12 -0.59
ROA 84.21 < 0.005 < 0.005
ROE 84.10 < 0.005 < 0.005
ROIC -82.72 < 0.005 -0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of VTR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of VTR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of VTR is permitted for members.
End of VTR's Analysis
CIK: 740260 CUSIP: 92276F100 ISIN: US92276F1003 LEI: - UEI: -
Secondary Listings